136 related articles for article (PubMed ID: 37991858)
21. Scleromyxedema.
Yang Y; Chen H; Zhang W; Sun JF
Indian J Dermatol Venereol Leprol; 2016; 82(6):738-739. PubMed ID: 26858056
[No Abstract] [Full Text] [Related]
22. Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema.
Brunet-Possenti F; Hermine O; Marinho E; Crickx B; Descamps V
J Am Acad Dermatol; 2013 Aug; 69(2):319-20. PubMed ID: 23866873
[No Abstract] [Full Text] [Related]
23. Scleromyxedema presenting with neurologic symptoms: a case report and review of the literature.
Marshall K; Klepeiss SA; Ioffreda MD; Helm KF
Cutis; 2010 Mar; 85(3):137-40. PubMed ID: 20408512
[TBL] [Abstract][Full Text] [Related]
24. [Scleromyxedema].
Neufeld M; Sunderkötter C; Moritz RKC
Hautarzt; 2018 Nov; 69(11):916-921. PubMed ID: 30135969
[TBL] [Abstract][Full Text] [Related]
25. Scleromyxedema.
Bogner RR; Wetter DA; Dingli D
Intern Med; 2014; 53(21):2561-2. PubMed ID: 25366027
[No Abstract] [Full Text] [Related]
26. Scleromyxedema.
Hummers LK
Curr Opin Rheumatol; 2014 Nov; 26(6):658-62. PubMed ID: 25215418
[TBL] [Abstract][Full Text] [Related]
27. Unusual granulomatous variant of scleromyxedema.
Stetsenko GY; Vary JC; Olerud JE; Argenyi ZB
J Am Acad Dermatol; 2008 Aug; 59(2):346-9. PubMed ID: 18485525
[TBL] [Abstract][Full Text] [Related]
28. Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
Wang SS; Chen QY; Xiang LH
Front Immunol; 2022; 13():1099918. PubMed ID: 36713453
[TBL] [Abstract][Full Text] [Related]
29. Scleromyxedema vs scleredema: a diagnostic challenge.
Conde Fernandes I; Sanches M; Velho G; Lobo I; Alves R; Selores M
Eur J Dermatol; 2011; 21(5):822-3. PubMed ID: 21771713
[No Abstract] [Full Text] [Related]
30. Myopathy and scleromyxedema.
Soulages A; Tang HM; Pham-Ledard A; Négrier-Leibreich ML; Cosnard A; Duval F; Solé G; Carla L; Le Masson G; Mathis S
J Neurol; 2019 Aug; 266(8):2051-2059. PubMed ID: 31115676
[TBL] [Abstract][Full Text] [Related]
31. Successful intravenous immunoglobulin treatment of atypical lichen myxedematosus associated with hypothyroidism and central nervous system involvement: case report and discussion of the literature.
Macnab M; Kenny P
J Cutan Med Surg; 2013; 17(1):69-73. PubMed ID: 23364155
[TBL] [Abstract][Full Text] [Related]
32. An unusual presentation of scleromyxedema as inflammatory myopathy.
Vysakha KV; Poyuran R; Nair SS; Nair M
Acta Myol; 2019 Mar; 38(1):13-16. PubMed ID: 31309176
[TBL] [Abstract][Full Text] [Related]
33. Scleromyxedema diagnosis following unexplained encephalopathy.
Rodrigues M; Machado A; Ventura F; Duarte ML; Ferreira C
Eur J Dermatol; 2008; 18(1):78-9. PubMed ID: 18086595
[No Abstract] [Full Text] [Related]
34. Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.
Rongioletti F; Cozzani E; Parodi A
J Cutan Pathol; 2010 Oct; 37(10):1084-7. PubMed ID: 19638067
[TBL] [Abstract][Full Text] [Related]
35. Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients.
Rongioletti F; Merlo G; Cinotti E; Fausti V; Cozzani E; Cribier B; Metze D; Calonje E; Kanitakis J; Kempf W; Stefanato CM; Marinho E; Parodi A
J Am Acad Dermatol; 2013 Jul; 69(1):66-72. PubMed ID: 23453242
[TBL] [Abstract][Full Text] [Related]
36. Scleroderma-like acute renal crisis in a patient with scleromyxedema.
Gwinner W; Erdbruegger U; Mengel M; Hafer C; Kittner J; Witte T; Voelker B; Haller H
Nephrol Dial Transplant; 2007 Jul; 22(7):2063-7. PubMed ID: 17389621
[No Abstract] [Full Text] [Related]
37. [Dermato-neuro syndrome during scleromyxedema: efficacy of plasmapheresis and intravenous immunoglobulin].
Charles S; Hainaut E; Cante V; Valette C; Levillain P; Guillet G
Ann Dermatol Venereol; 2014; 141(8-9):523-7. PubMed ID: 25209816
[TBL] [Abstract][Full Text] [Related]
38. Dermato-neuro syndrome associated with scleromyxedema.
Karaman B; Guler A; Ertam I; Celebisoy N
Indian J Dermatol Venereol Leprol; 2015; 81(5):519-21. PubMed ID: 26261151
[No Abstract] [Full Text] [Related]
39. Scleromyxedema.
Liu CH; Tsai YY; Tien YC
Rheumatology (Oxford); 2022 Jul; 61(7):e201-e200. PubMed ID: 34554227
[No Abstract] [Full Text] [Related]
40. Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin.
Körber A; Franckson T; Grabbe S; Dissemond J
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):553-4. PubMed ID: 17373996
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
